Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.470
-0.040 (-2.65%)
Jun 29, 2026, 2:06 PM EST
Cardiol Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
174.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 78.76K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ascend Wellness Holdings | 683.30M |
| TerrAscend | 365.43M |
| Aurora Cannabis | 320.59M |
| Organigram Global | 274.19M |
| Auxly Cannabis Group | 158.57M |
| Medexus Pharmaceuticals | 138.65M |
| Cannara Biotech | 113.01M |
| HLS Therapeutics | 77.81M |
Cardiol Therapeutics News
- 4 days ago - Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders - PRNewsWire
- 6 days ago - Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT - PRNewsWire
- 6 weeks ago - Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ - PRNewsWire
- 6 weeks ago - Cardiol Therapeutics Registration statement: Q1 2026 - Filings
- 6 weeks ago - Cardiol Therapeutics Registration statement: Q1 2026 - Filings
- 7 weeks ago - Cardiol Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association - PRNewsWire
- 2 months ago - Cardiol Therapeutics (CRDL) Expands MAVERIC Trial with New Clinical Sites - GuruFocus